Seeing Is Believing
Currently out of the existing stock ratings of Jonathan Wolleben, 195 are a BUY (100%).
Analyst Jonathan Wolleben, currently employed at JMP, carries an average stock price target met ratio of 21.23% that have a potential upside of 36.17% achieved within 129 days.
Jonathan Wolleben’s has documented 379 price targets and ratings displayed on 20 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on DBVT, DBV Technologies at 27-May-2025.
Analyst best performing recommendations are on DBVT (DBV TECHNOLOGIES).
The best stock recommendation documented was for DBVT (DBV TECHNOLOGIES) at 3/4/2025. The price target of $10 was fulfilled within 69 days with a profit of $5.7 (132.56%) receiving and performance score of 19.21.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$12
$4.97 (70.70%)
$12
2 months 19 days ago
(03-Apr-2025)
0/17 (0%)
$7.54 (169.06%)
Buy
$25
$17.97 (255.62%)
$25
2 months 20 days ago
(02-Apr-2025)
0/15 (0%)
$20.22 (423.01%)
Buy
$20
$12.97 (184.50%)
$20
10 months 10 days ago
(12-Aug-2024)
4/16 (25%)
$13.78 (221.54%)
214
Buy
$25
$17.97 (255.62%)
$25
1 years 1 days ago
(21-Jun-2024)
3/14 (21.43%)
$18.59 (290.02%)
42
Hold
$26
1 years 1 months 24 days ago
(29-Apr-2024)
0/6 (0%)
$12.36 (90.62%)
Which stock is Jonathan Wolleben is most bullish on?
Which stock is Jonathan Wolleben is most reserved on?
What Year was the first public recommendation made by Jonathan Wolleben?